GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1 ... according to a preliminary study to be presented at the American Heart Association's Scientific Sessions ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...

Fear of another heart attack was a significant ongoing contributor to how heart attack survivors perceive their health, ...

Fear of another heart attack was a significant ongoing contributor to how heart attack survivors perceive their health, according ...

The preliminary data will be presented at the American Heart Association’s Resuscitation Science Symposium on November 16 and 17. Cardiac arrest happens when the heart malfunctions and abruptly stops ...

Stroke survivors can significantly lower their risk of another stroke, a heart attack or premature death by taking a diabetes drug like Ozempic or Jardiance, new preliminary research finds.

A few days after Mindy Beyer was born, doctors delivered crushing news to her parents: You'll be lucky if your baby lives until age 3. Mindy was born with a variety of heart problems. Her ventricles ...